Kronos Bio, Inc.
KRON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9,848 | $6,288 | $0 | $0 |
| % Growth | 56.6% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $4,463 | $4,081 |
| Gross Profit | $9,848 | $6,288 | -$4,463 | -$4,081 |
| % Margin | 100% | 100% | – | – |
| R&D Expenses | $48,664 | $86,379 | $93,715 | $112,903 |
| G&A Expenses | $24,616 | $41,739 | $43,400 | $38,495 |
| SG&A Expenses | $24,616 | $41,739 | $43,400 | $38,495 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $29,455 | $0 | $0 | $0 |
| Operating Expenses | $102,735 | $128,118 | $137,115 | $151,398 |
| Operating Income | -$92,887 | -$121,830 | -$137,115 | -$151,398 |
| % Margin | -943.2% | -1,937.5% | – | – |
| Other Income/Exp. Net | $6,808 | $9,157 | $3,911 | $320 |
| Pre-Tax Income | -$86,079 | -$112,673 | -$133,204 | -$151,078 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$86,079 | -$112,673 | -$129,293 | -$149,101 |
| % Margin | -874.1% | -1,791.9% | – | – |
| EPS | -1.43 | -1.95 | -2.3 | -2.72 |
| % Growth | 26.7% | 15.2% | 15.4% | – |
| EPS Diluted | -1.43 | -1.95 | -2.3 | -2.72 |
| Weighted Avg Shares Out | 60,070 | 57,744 | 56,201 | 54,754 |
| Weighted Avg Shares Out Dil | 60,070 | 57,744 | 56,201 | 54,754 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6,808 | $9,157 | $3,911 | $320 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,716 | $2,136 | $4,463 | $4,081 |
| EBITDA | -$61,716 | -$119,694 | -$128,741 | -$146,997 |
| % Margin | -626.7% | -1,903.5% | – | – |